Isovitexin is a phytochemical with a reasonable bioactivity and safety profile for use in humans, and it can potentially be used as a hACE2-specific therapeutic to inhibit COVID-19 infection.
No takes yet. Share an insight, caveat, or question.
Ferdausi et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: